项目名称

Project

牛津大学牛津心磁图仪有限公司（量子超导干涉仪）

(SQUIDs)（(SQUIDs)）

项目地点

Location

英国牛津

Oxford, UK

项目持有人

Project Provider

(SQUIDs)

所属行业

Industry

医疗器械

Medical Equipment

项目有效期

Project Validity

-

合作描述

Description

2014年牛津大学创新中心创立了牛津心磁图仪有限公司，其核心技术来源于乌克兰国家科学院。2016年在中国成立了姊妹公司，获得当地政府的支持，便于进入中国市场。公司与2014年获得200万英镑的种子基金，这些资金用于中国和欧盟的医疗器械审批工作。现在，公司融资300万英镑，用于加速中国市场开发和完成欧盟及美国审批工作。

Oxford Cardiomox Ltd was formed in 2014 by  Oxford University Innovation Ltd. The technology was identified during a  consulting project to support a leading Ukrainian medical research institute.  A Chinese sister company was created in 2016 to access government support and  ease entry to the Chinese market. The company raised £2m in 2014 and these  funds are being used to complete the regulatory approval process for the  current Cardiomox MCG scanner in China and Europe. Oxford Cardiomox Ltd is  now seeking GBP 3 million to accelerate sales in China and support entry to  the US market.

项目重点

Key Facts

极度灵敏的磁场感应器（量子超导干涉仪）辅以独特的计算机软件可以检测心脏的电生理状况，并以电流密度图谱来表达，同时也可以应用人工智能自动分析诊断结果。该设备可以帮助心脏病医师确定早期冠心病（通常在出现症状之前），也可以快速确定心律失常和其它心脏疾病。心磁图仪可以用于大规模健康检查。

Extremely sensitive magnetic sensors  (SQUIDs) combined with unique software are used to create a current density vectors  map and can automatically analyse the result, which in turn, reflects the  electrophysiological condition of the heart. This system helps cardiologists  identify the early signs of Coronary Artery Disease (often before symptoms  occur). It supports rapid identification of arrhythmias and other heart  conditions and the technology can be used in large scale health checks or  screening.

资金使用

Use of funds

资金将会用于加速中国市场的开发，欧盟审批及进入美国市场（FDA的审批将在欧盟及中国审批之后进行）。

Funds will be used to accelerate  entry to the Chinese market, obtain CE certification, and support entry into  the US market (FDA approval to build upon CE and CFDA approvals)

Investment Sought

投资金额

£3 million

300万英镑

合作方条件

Partner Request

-